Guilford (GLFD) - Steadily Rising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Merritt who wrote (262)	1/8/1999 11:33:00 PM
From: Steve	Read Replies (1) of 496

Well, the market is hitting new highs and our loved one, GLFD, is looking pretty weak. I seriously hope that Dr. Smith and Company have something different and of interest to the investment community when they present next week at the H & Q Biotech Conference. Does anybody know what day they present? If he doesn't come up with something to keep this stock from falling (even a sale will do), I think he should resign. The board of directors has a fiduciary duty to prevent our investment from going to zero (at this point trying to maximize return on our investment is out the door. Just give me my money back). Other biotechs are doing well. GLFD has too much selling going into it. The business model that Dr. Smith so proudly wrote about in last year's annual report is not working. Amgen doesn't seem to be in much of a hurry to commercialize NIL-A. I don't know how the shareholders can tolerate what has happened to this company. Basically we are all at the mercy of these larger pharma companies. Hell, why not just sell to them then. I don't get it. Is anybody else bothered by the record level of short interest in the stock.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next